1. Regulation of PDE-4 cAMP phosphodiesterases by phosphatidic acid

   • Muriel Grange
   • Madeleine Picq
   • Georges Nemoz

   Feature Head Pages: 1 - 17

2. Signaling role of PDE isozymes in pathobiology of glomerular mesangial cells

   • Thomas P. Dousa

   Feature Head Pages: 19 - 34

3. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity

   • D. H. Maurice

   Feature Head Pages: 35 - 47

4. Cyclic nucleotide PDE-3

   • Tadasu Nagaoka
   • Taku Shirakawa
   • Yoko Fujita-Yamaguchi

   Feature Head Pages: 49 - 66

5. Downregulation of right ventricular phosphodiesterase PDE-3A mRNA and protein before the development of canine heart failure

   • Carolyn J. Smith
   • JingZhi He
   • Thomas H. Hintze

   Feature Head Pages: 67 - 88

6. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3)

   • Rui He
   • Narcisse Komas
   • Vincent C. Manganiello

   Feature Head Pages: 89 - 111

7. CDP840

   • M. J. Perry
   • J. O’Connell
   • R. J. Owens

   Feature Head Pages: 113 - 132

8. The γ-subunit of the rod photoreceptor cGMP-binding cGMP-specific PDE is expressed in mouse lung

   • Rothwelle J. Tate
   • Amanda Lochhead
   • Nigel J. Pyne

   Feature Head Pages: 133 - 144

9. A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5)

   • Jackie D. Corbin
   • Alfreda Beasley
   • Konjeti R. Sekhar

   Feature Head Pages: 145 - 157

10. Characterization of CHO-K1 cells stably expressing PDE-IV enzymes

    • D. J. Pon
    • M. Plant
    • I. W. Rodger

    Feature Head Pages: 159 - 178

11. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-α generation from human peripheral blood monocytes

    • Paul M. Seldon
    • Peter J. Barnes
    • Mark A. Giembycz

    Feature Head Pages: 179 - 201